-The Economic Times Drug companies paid as little as 50,000 as compensation to families of volunteers who died during clinical trials for new medicines last year, leading to sharp criticism about the paltry sums being handed out and growing clamour among health groups for more stringent guidelines on new drug trials.  According to government data accessed by a healthcare activist through an RTI query, Germany's Fresenius Kabi paid 50,000 each to the...

-The Hindu One in five women who die during childbirth globally belong to India: WHO Bad roads, poor connectivity and unavailability of transport at night continue to force more than one- third of pregnant women in Jharkhand to deliver at home. “More than 80 per cent of these women who deliver at home are unable to arrange for transport to reach a healthcare facility,” noted a study, conducted by Public Health Foundation of...

-The Telegraph A global effort to create a vaccine against the human immunodeficiency virus (HIV) that has abandoned dozens of candidate vaccines because of unsatisfactory trials has persuaded India to join its new vaccine-design strategy. The Translational Health Sciences and Technology Institute, a government research centre in a Haryana suburb near Delhi, will set up a laboratory for basic research to seek out molecules that can generate antibodies to effectively neutralise HIV. India’s...

-The Economic Times India has some of the best quaternary and tertiary care in the world and is gradually acquiring a name for itself even in the field of 'medical tourism'. Secondary care is still a significant challenge, but even in several smaller towns and district headquarters, there is a growing supply of maternity homes and multi-speciality secondary care facilities. At all of these levels of care, given the large disease burden...

-The Indian Express At a time when the government is struggling to get past objections from its coalition partners to attract investment in certain sectors such as retail, aviation and pensions fund management, a grim internecine ministerial battle has applied the brakes on foreign direct investment flow into one of the more attractive and lucrative sectors — pharmaceuticals. Clearances for over Rs 1,000 crore FDI in this sector, the second largest in...